BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26746204)

  • 1. Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors.
    Sharma V; Purkait S; Takkar S; Malgulwar PB; Kumar A; Pathak P; Suri V; Sharma MC; Suri A; Kale SS; Kulshreshtha R; Sarkar C
    Brain Tumor Pathol; 2016 Apr; 33(2):117-28. PubMed ID: 26746204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low- and high-grade astrocytic tumors.
    Sharma V; Malgulwar PB; Purkait S; Patil V; Pathak P; Agrawal R; Kulshreshtha R; Mallick S; Julka PK; Suri A; Sharma BS; Suri V; Sharma MC; Sarkar C
    Carcinogenesis; 2017 Feb; 38(2):152-161. PubMed ID: 27993893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
    Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Salomo K; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2249-61. PubMed ID: 27562865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2.
    Lin L; Zheng Y; Tu Y; Wang Z; Liu H; Lu X; Xu L; Yuan J
    Hum Pathol; 2015 Jul; 46(7):971-80. PubMed ID: 25907866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
    Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
    Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.
    Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
    Mol Neurobiol; 2017 Dec; 54(10):8162-8169. PubMed ID: 27900675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects.
    Paskeh MDA; Mehrabi A; Gholami MH; Zabolian A; Ranjbar E; Saleki H; Ranjbar A; Hashemi M; Ertas YN; Hushmandi K; Mirzaei S; Ashrafizadeh M; Zarrabi A; Samarghandian S
    Biomed Pharmacother; 2022 Feb; 146():112532. PubMed ID: 34906772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability.
    Zhai X; Li LS; Zhou YD; Ji WY; Chen H; Xiao H; Liang P
    Eur J Pharmacol; 2021 Aug; 904():174177. PubMed ID: 34015321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
    Ahmed S; Rashed H; Hegazy A; Mohamed AM; Elmesallamy W
    Turk Patoloji Derg; 2016; 32(2):70-81. PubMed ID: 27136105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-708 acts as a tumor suppressor in human glioblastoma cells.
    Guo P; Lan J; Ge J; Nie Q; Mao Q; Qiu Y
    Oncol Rep; 2013 Aug; 30(2):870-6. PubMed ID: 23754151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
    Cheng T; Xu Y
    Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
    Alzrigat M; Párraga AA; Agarwal P; Zureigat H; Österborg A; Nahi H; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
    Oncotarget; 2017 Feb; 8(6):10213-10224. PubMed ID: 28052011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis.
    Smits M; Nilsson J; Mir SE; van der Stoop PM; Hulleman E; Niers JM; de Witt Hamer PC; Marquez VE; Cloos J; Krichevsky AM; Noske DP; Tannous BA; Würdinger T
    Oncotarget; 2010 Dec; 1(8):710-20. PubMed ID: 21321380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma.
    Wang J; Liu Z; Cui Y; Liu Y; Fang J; Xu L; He Y; Du J; Su Y; Zou W; Xu Z; Li G
    J Neurooncol; 2019 Aug; 144(1):137-146. PubMed ID: 31214915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer.
    Vishnubalaji R; Hamam R; Abdulla MH; Mohammed MA; Kassem M; Al-Obeed O; Aldahmash A; Alajez NM
    Cell Death Dis; 2015 Jan; 6(1):e1614. PubMed ID: 25611389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.
    Lu J; He ML; Wang L; Chen Y; Liu X; Dong Q; Chen YC; Peng Y; Yao KT; Kung HF; Li XP
    Cancer Res; 2011 Jan; 71(1):225-33. PubMed ID: 21199804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.